GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BetterLife Pharma Inc (STU:NPAU) » Definitions » Effective Interest Rate on Debt %

BetterLife Pharma (STU:NPAU) Effective Interest Rate on Debt % : 13.89% (As of Jan. 2024)


View and export this data going back to 2018. Start your Free Trial

What is BetterLife Pharma Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. BetterLife Pharma's annualized positive value of Interest Expense for the quarter that ended in Jan. 2024 was €0.10 Mil. BetterLife Pharma's average total debt for the quarter that ended in Jan. 2024 was €0.72 Mil. Therefore, BetterLife Pharma's annualized Effective Interest Rate on Debt % for the quarter that ended in Jan. 2024 was 13.89%.


BetterLife Pharma Effective Interest Rate on Debt % Historical Data

The historical data trend for BetterLife Pharma's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BetterLife Pharma Effective Interest Rate on Debt % Chart

BetterLife Pharma Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Effective Interest Rate on Debt %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.81 1.41 5.78 5.12 3.84

BetterLife Pharma Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.72 0.51 2.08 3.24 13.89

Competitive Comparison of BetterLife Pharma's Effective Interest Rate on Debt %

For the Biotechnology subindustry, BetterLife Pharma's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BetterLife Pharma's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BetterLife Pharma's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where BetterLife Pharma's Effective Interest Rate on Debt % falls into.



BetterLife Pharma Effective Interest Rate on Debt % Calculation

BetterLife Pharma's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Jan. 2024 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Jan. 2023 )+Total Debt  (A: Jan. 2024 ))/ count )
=-1  *  -0.035/( (0.82+1.005)/ 2 )
=-1  *  -0.035/0.9125
=3.84 %

where

Total Debt  (A: Jan. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.304 + 0.516
=0.82

Total Debt  (A: Jan. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.629 + 0.376
=1.005

BetterLife Pharma's annualized Effective Interest Rate on Debt % for the quarter that ended in Jan. 2024 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Oct. 2023 )+Total Debt  (Q: Jan. 2024 ))/ count )
=-1  *  -0.1/( (0.435+1.005)/ 2 )
=-1  *  -0.1/0.72
=13.89 %

where

Total Debt  (Q: Oct. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.38 + 0.055
=0.435

Total Debt  (Q: Jan. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.629 + 0.376
=1.005

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Jan. 2024) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.


BetterLife Pharma  (STU:NPAU) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


BetterLife Pharma Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of BetterLife Pharma's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.


BetterLife Pharma (STU:NPAU) Business Description

Industry
Traded in Other Exchanges
Address
1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6
BetterLife Pharma Inc a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus, and/or to directly inhibit tumors to treat various types of cancer.

BetterLife Pharma (STU:NPAU) Headlines

No Headlines